R&D

Providing innovative growth and harvest information, based on validated and reproducible scientific data.

read more

SERVICES

Offering a variety of specialized solutions through our qualifications, knowledge and experience.

read more

Home_Feature_Links_Facility
« 1 of 22 »

THC BioMed is an organization strategically located in beautiful Kelowna, BC that is devoted to Research & Development, plant innovation and life sciences, with the emphasis on Medical Cannabis.

Medical Cannabis is still an emerging industry, as such, it is imperative that substantiated scientific data and evidence is brought to the forefront, delivering educational knowledge to break down the barriers, where only anecdotal information survived before.

By providing scientific and biotechnological support services to a target demographic that includes current and potential licensed producers under the Marihuana for Medical Purposes Regulations (MMPR), we are able to strengthen the current regulated standards, while helping to establish a robust and safe source of medical marihuana.

We remain committed to working closely with your team, to instil confidence in our product, while meeting your objective. Whether your focus is regulatory compliance solutions to conform to the MMPR, adding genetic diversity, horticultural training, integration of innovative production methods to increase yield, third party analytical testing (at all stages of growth), training in Quality Assurance, or you’re interested in collaborating with us to develop and test your product to meet the industry standards, we will provide services that are fully customized and unique for every client.

MMPR News & Updates

THC Announces $10,000,000 Capital Commitment

March 16th, 2017|Comments Off on THC Announces $10,000,000 Capital Commitment

THC BioMed Begins Shipping Live Cannabis Plants across Canada to ACMPR Registered Patients and Announces Wholesale Genetic Pricing

January 23rd, 2017|Comments Off on THC BioMed Begins Shipping Live Cannabis Plants across Canada to ACMPR Registered Patients and Announces Wholesale Genetic Pricing

Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing – THC to Expand its Facilities

December 20th, 2016|Comments Off on Health Canada Issues THC BioMed amendment to Sell Starting Materials and Grants THC Permission to Conduct In-House Analytical Testing – THC to Expand its Facilities